Albany, NY -- (SBWIRE) -- 08/05/2019 -- Traumatic Brain Injury Market Insights, Epidemiology and Market Forecast-2028
1. Approximately 2.8 million people sustain Traumatic Brain Injury annually in the United States.
2. About 57,000 Traumatic Brain Injury related deaths and 1-5 million hospital discharges occurred in 2012 in Europe.
3. Traumatic Brain Injury accounts for 9.3% of 1,160,000 traffic accident injuries.
DelveInsight launched a new report on Traumatic Brain Injury Market Insights, Epidemiology and Market Forecast-2028
Key benefits
1. Traumatic Brain Injury market report covers a descriptive overview and comprehensive insight of the Traumatic Brain Injury Epidemiology and Traumatic Brain Injury market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Traumatic Brain Injury market report provides insights into current and emerging therapies.
3. Traumatic Brain Injury market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Traumatic Brain Injury market report offers an edge that will aid in creating business strategies by comprehending trends that shape and drive the Traumatic Brain Injury market.
Request for sample pages
"Traumatic Brain Injury rate related deaths decreased from 27.8 to 25.4 per 100,000 in men and rate in women decreased from 9.6 to 9.0 per 100,000."
Currently, there is no approved therapy for Traumatic Brain Injury Treatment. Treatment management is based on the avoidance of secondary injury, maintenance of cerebral perfusion pressure, and optimization of cerebral oxygenation. Patients with mild traumatic injuries do not require specific treatment other than the OTC pain relievers. However, for Traumatic Brain Injury treatment, there are various medications indicated that include diuretics, anti-seizure drugs, etc. In some cases, moderate to severe TBI, surgery, and rehabilitation is also required.
The existing medications being used for those suffering from traumatic brain injury are focused on treating Traumatic Brain Injury symptoms and stopping the pain instead of protecting any further damage from occurring. To overcome this shortcoming of the Traumatic Brain Injury therapeutic market and to provide better Traumatic Brain Injury treatment options for the moderate to the severe patient pool, many molecules are being explored at different levels. Few of them are able to reach the late phase clinical trials focusing on moderate to severe patient's pool to restrict further secondary damage or injury and improves the overall outcomes, but the continuous failure of drugs at late-stage clinical trials is a major concern of Traumatic Brain Injury therapeutic market.
The launch of the emerging therapies is expected to significantly impact the Traumatic Brain Injury treatment scenario in the upcoming years:-
Drugs covered
1. NeuroSTAT
2. Ronopterin
And many others
The key players in Traumatic Brain Injury market are:
1. NeuroVive Pharmaceutical AB
2. Vasopharm GmbH
And many others
Table of contents
1. Report Introduction
2. Traumatic Brain Injury Market Overview at a Glance
3. Traumatic Brain Injury Disease Background and Overview
4. Traumatic Brain Injury Epidemiology and Patient Population
4.4.1. United States
4.4.2. EU5
4.4.2.1. Germany
4.4.2.2. Italy
4.4.2.3. Spain
4.4.2.4. France
4.4.2.5. United Kingdom
4.4.3. Japan
5. Traumatic Brain Injury Current Treatment and Medical Practices
6. Traumatic Brain Injury Current Unmet Needs
7. Traumatic Brain Injury Emerging Therapies
7.1. Key Cross Competition
7.2. Ronopterin (VAS203): Vasopharm GmbH
7.3. NeuroSTAT: NeuroVive Pharmaceutical AB
8. Traumatic Brain Injury Market Outlook
8.1. Key Findings
9. 7MM: Country-Wise Market Analysis (2016-2027)
9.1. United States Market Size
9.2. Germany Market Size
9.3. France Market Size
9.4. United Kingdom Market Size
9.5. Spain Market Size
9.6. Italy Market Size
9.7. Japan
10. Market drivers
11. Market barriers
12. Appendix
13. Traumatic Brain Injury Report Methodology
14. DelveInsight Capabilities
15. Disclaimer
16. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Contact us:
Shruti Thakur
info@delveinsight.com
+919650213330
SOURCE DelveInsight